213 related articles for article (PubMed ID: 25336126)
1. [Clinical application, limits and perspectives of pharmacogenetic and pharmacokinetic analysis of anticancer drugs].
Chantry AS; Quaranta S; Ciccolini J; Lacarelle B
Ann Biol Clin (Paris); 2014; 72(5):527-42. PubMed ID: 25336126
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics and pharmacogenomics of anticancer agents.
Huang RS; Ratain MJ
CA Cancer J Clin; 2009; 59(1):42-55. PubMed ID: 19147868
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacogenetics of anticancer drugs].
de Chaisemartin L; Loriot MA
Pathol Biol (Paris); 2005 Mar; 53(2):116-24. PubMed ID: 15708657
[TBL] [Abstract][Full Text] [Related]
4. Ethnic differences in the metabolism, toxicology and efficacy of three anticancer drugs.
Sai K; Saito Y
Expert Opin Drug Metab Toxicol; 2011 Aug; 7(8):967-88. PubMed ID: 21585235
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic and Pharmacogenetic Markers of Irinotecan Toxicity.
Hahn RZ; Antunes MV; Verza SG; Perassolo MS; Suyenaga ES; Schwartsmann G; Linden R
Curr Med Chem; 2019; 26(12):2085-2107. PubMed ID: 29932028
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetic and Pharmacokinetic Dose Individualization of the Taxane Chemotherapeutic Drugs Paclitaxel and Docetaxel.
Andriguetti NB; Raymundo S; Antunes MV; Perassolo MS; Verza SG; Suyenaga ES; Linden R
Curr Med Chem; 2017; 24(33):3559-3582. PubMed ID: 28641556
[TBL] [Abstract][Full Text] [Related]
7. Treatment of metastatic pancreatic adenocarcinoma: a comprehensive review.
Kozuch P; Petryk M; Evans A; Bruckner HW
Surg Clin North Am; 2001 Jun; 81(3):683-90. PubMed ID: 11459281
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetic tests in cancer chemotherapy: what physicians should know for clinical application.
Lee SY; McLeod HL
J Pathol; 2011 Jan; 223(1):15-27. PubMed ID: 20818641
[TBL] [Abstract][Full Text] [Related]
9. Application of pharmacokinetic modelling to the routine therapeutic drug monitoring of anticancer drugs.
Rousseau A; Marquet P
Fundam Clin Pharmacol; 2002 Aug; 16(4):253-62. PubMed ID: 12570013
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomics: road to anticancer therapeutics nirvana?
Desai AA; Innocenti F; Ratain MJ
Oncogene; 2003 Sep; 22(42):6621-8. PubMed ID: 14528287
[TBL] [Abstract][Full Text] [Related]
11. Integrating pharmacogenetics into gemcitabine dosing--time for a change?
Ciccolini J; Mercier C; Dahan L; André N
Nat Rev Clin Oncol; 2011 Feb; 8(7):439-44. PubMed ID: 21304503
[TBL] [Abstract][Full Text] [Related]
12. Novel oral chemotherapy agents.
Royce ME; Hoff PM; Pazdur R
Curr Oncol Rep; 2000 Jan; 2(1):31-7. PubMed ID: 11122822
[TBL] [Abstract][Full Text] [Related]
13. Effects of cigarette smoking on metabolism and effectiveness of systemic therapy for lung cancer.
O'Malley M; King AN; Conte M; Ellingrod VL; Ramnath N
J Thorac Oncol; 2014 Jul; 9(7):917-926. PubMed ID: 24926542
[TBL] [Abstract][Full Text] [Related]
14. Genotypes Affecting the Pharmacokinetics of Anticancer Drugs.
Bertholee D; Maring JG; van Kuilenburg AB
Clin Pharmacokinet; 2017 Apr; 56(4):317-337. PubMed ID: 27641154
[TBL] [Abstract][Full Text] [Related]
15. Irinotecan Plus Gemcitabine and Fluorouracil in Advanced Biliary Tract Cancer: A Retrospective Study.
Endlicher E; Schnoy E; Troppmann M; Rogler G; Messmann H; Klebl F; Gelbmann C; Kullmann F
Digestion; 2016; 93(3):229-33. PubMed ID: 27089254
[TBL] [Abstract][Full Text] [Related]
16. [Irinotecan pharmacogenetics in Japanese cancer patients: roles of UGT1A1*6 and *28].
Sai K; Sawada J; Minami H
Yakugaku Zasshi; 2008 Apr; 128(4):575-84. PubMed ID: 18379174
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapeutic agents eligible for prior dosing in pancreatic cancer patients requiring hemodialysis: a systematic review
.
Hann A; Nosalski E; Hermann PC; Egger J; Seufferlein T; Keller F
Clin Nephrol; 2018 Aug; 90(2):125-141. PubMed ID: 29578402
[TBL] [Abstract][Full Text] [Related]
18. Genetic tests for predicting the toxicity and efficacy of anticancer chemotherapy.
Mladosievicova B; Carter A; Kristova V
Neoplasma; 2007; 54(3):181-8. PubMed ID: 17447847
[TBL] [Abstract][Full Text] [Related]
19. Toward individualized treatment: prediction of anticancer drug disposition and toxicity with pharmacogenetics.
Deeken JF; Figg WD; Bates SE; Sparreboom A
Anticancer Drugs; 2007 Feb; 18(2):111-26. PubMed ID: 17159598
[TBL] [Abstract][Full Text] [Related]
20. New anticancer agents in clinical development.
Eckardt J; Eckhardt G; Villalona-Calero M; Drengler R; Von Hoff D
Oncology (Williston Park); 1995 Dec; 9(12):1321-8; 1331; discussion 1332-4. PubMed ID: 8771106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
